acetylgalactosamine has been researched along with Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Z; Li, R; Li, Z; Liang, X; Liu, S; Shi, W; Xin, G; Xu, LX; Ye, ZM; Zhang, B | 1 |
| Xu, LX; Yan, Y; Zhang, JJ; Zhang, Y; Zhao, MH | 1 |
2 other study(ies) available for acetylgalactosamine and Sclerosis
| Article | Year |
|---|---|
N-acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of IgA nephropathy patients.
Topics: Acetylgalactosamine; Adult; Atrophy; Female; Fibrosis; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Regression Analysis; Sclerosis | 2014 |
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Topics: Acetylgalactosamine; Adult; Chemical Precipitation; Female; Galactose; Glomerulonephritis, IGA; Glycosylation; Humans; Immunoglobulin A; Immunoglobulin G; Kidney Glomerulus; Lectins; Macromolecular Substances; Male; N-Acetylneuraminic Acid; Phenotype; Polysaccharides; Sclerosis; Severity of Illness Index | 2005 |